Antiretroviral drugs

Delamanid ( Deltyba ), a nitroimidazo-oxazole derivative, is a new anti-tuberculosis ( TB ) drug which exhibits potent in vitro...


Results from studies in chronic hepatitis C patients with human immunodeficiency virus type 1 ( HIV-1 ) co-infection ( TURQUOISE-I...


The optimum dose of key antiretroviral drugs is often overlooked during product development. The ENCORE1 study compared the efficacy and...


Health Canada has received a published case report of a potential drug-herb interaction between Efavirenz ( Sustiva ) and a...


Dolutegravir ( Tivicay ), a once-daily HIV integrase inhibitor, has shown potent antiviral response and a favourable safety profile. Researchers...


Gilead Sciences has announced results from a phase 3 study, PHOTON-1, evaluating the investigational once-daily nucleotide analogue Sofosbuvir for the...


Gilead Sciences has announced that the Antiviral Drugs Advisory Committee of the FDA ( Food and Drug Administration ) has...


The way the body metabolizes an anti-retroviral drug that is used long term by patients infected with virus HIV may...


Stribild contains four compounds in a complete once-daily, single tablet regimen: Elvitegravir 150 mg; Cobicistat 150 mg; Emtricitabine 200 mg;...


The FDA ( Food and Drug Administration ) has approved Stribild ( Elvitegravir 150 mg / Cobicistat 150 mg /...


Even with effective anti-HIV therapies, physicians still have not been able to eradicate the virus from infected individuals who are...


The FDA ( Food and Drug Administration ) has approved Atripla, a fixed-dose combination of three widely-used antiretroviral drugs, in...


A study on HIV patients who also had hepatitis B virus ( HBV ) found that better outcomes are possible...


Some HIV medications lead to the development of drug-resistant HIV when patients take as few as two percent of their...


Researchers at Johns Hopkins and other institutions has found that a once-daily combination of three antiretroviral drugs works better as...


The data from a phase I/II study showed significant reductions in viral load among HIV-positive patients receiving GS 9137,...


Researchers at Mayo Clinic have discovered a way to dramatically boost the output of immune system cells from the thymus,...


CDC ( Centers for Disease Control and Prevention ) has announced new guidelines for the use of antiretroviral drugs to...


Patients previously treated with three classes of antiretrovirals can achieve maximal viral suppression when starting a regimen of Enfuvirtide (...


By studying animals, Johns Hopkins researchers have discovered that the antibiotic Minocycline ( Minocin ) might help alleviate HIV's negative...